|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7398 USD | +5.06% |
|
-2.77% | -2.27% |
PaxMedica, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 18.29 million compared to USD 14.8 million a year ago. Basic loss per share from continuing operations was USD 11 compared to USD 28.79 a year ago.
Diluted loss per share from continuing operations was USD 11 compared to USD 28.79 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -2.27% | 5.52M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
PAXMEDICA, INC. 
